Copy to clipboard 
OrthoPediatrics (KIDS) posted 1Q18 revenue of US $12.1MM, +23.9% vs. 1Q17.
| 1Q18 | 1Q17 | $ Change | % Change | |
| Â Trauma | $9.1Â | $7.7Â | $1.4Â | 17.9%Â |
| Â Spine | $2.7Â | $1.9Â | $0.8Â | 39.7%Â |
| Â Arthroscopy/Soft Tissue Repair | $0.3Â | $0.1Â | $0.2Â | 186.0%Â |
| Total | $12.1 | $9.8 | $2.3 | 23.9% |
While all three segments contributed to growth, leadership singled out strong U.S. scoliosis sales and strength in ex-U.S. regions, as well.
Within the quarter, KIDS increased investment in consigned sets to $5.5MM, and affirmed that they are on target to increase investments in set deployment to $10MM for the full year. Nine U.S. sales reps joined in 1Q, for a total of 84 reps focusing exclusively on the company. Overseas, KIDS added two new stocking distributors for a total of 37.
KIDS is launching five new surgical systems in 2018, starting with Titanium PediPlates and an upgrade to the PediFlex Advanced system. Others to come include an Osteogenesis Imperfecta Nail and PediFoot, which leadership claims will be the first pediatric fracture system for the foot.
After the quarter’s close, KIDS announced FDA 510(k) clearance for the Pediatric Nailing Platform | FEMUR, its 25th surgical system. This is the second lower extremity IM nail system that the company will launch this year.
Source: OrthoPediatrics Corp.
OrthoPediatrics (KIDS) posted 1Q18 revenue of US $12.1MM, +23.9% vs. 1Q17.
Q18Â
Q17Â
$ ChangeÂ
% ChangeÂ
 Trauma
$9.1Â
$7.7Â
$1.4Â
17.9%Â
 Spine...
OrthoPediatrics (KIDS) posted 1Q18 revenue of US $12.1MM, +23.9% vs. 1Q17.
| 1Q18 | 1Q17 | $ Change | % Change | |
| Â Trauma | $9.1Â | $7.7Â | $1.4Â | 17.9%Â |
| Â Spine | $2.7Â | $1.9Â | $0.8Â | 39.7%Â |
| Â Arthroscopy/Soft Tissue Repair | $0.3Â | $0.1Â | $0.2Â | 186.0%Â |
| Total | $12.1 | $9.8 | $2.3 | 23.9% |
While all three segments contributed to growth, leadership singled out strong U.S. scoliosis sales and strength in ex-U.S. regions, as well.
Within the quarter, KIDS increased investment in consigned sets to $5.5MM, and affirmed that they are on target to increase investments in set deployment to $10MM for the full year. Nine U.S. sales reps joined in 1Q, for a total of 84 reps focusing exclusively on the company. Overseas, KIDS added two new stocking distributors for a total of 37.
KIDS is launching five new surgical systems in 2018, starting with Titanium PediPlates and an upgrade to the PediFlex Advanced system. Others to come include an Osteogenesis Imperfecta Nail and PediFoot, which leadership claims will be the first pediatric fracture system for the foot.
After the quarter’s close, KIDS announced FDA 510(k) clearance for the Pediatric Nailing Platform | FEMUR, its 25th surgical system. This is the second lower extremity IM nail system that the company will launch this year.
Source: OrthoPediatrics Corp.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
